Eledon Pharmaceuticals, Inc. Other Comprehensive Income (Loss), Net of Tax
Eledon Pharmaceuticals, Inc. (ELDN) reported Other Comprehensive Income (Loss), Net of Tax of -$42.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- Eledon Pharmaceuticals, Inc. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$42.00K.
- Eledon Pharmaceuticals, Inc. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$96.00K.
- Eledon Pharmaceuticals, Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $57.00K, a 44.12% decline year-over-year.
- Eledon Pharmaceuticals, Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-06-30 was -$30.00K.
- Eledon Pharmaceuticals, Inc. other comprehensive income (loss), net of tax for fiscal 2025 was -$2.00K, a 107.69% decline from fiscal 2024.
- Eledon Pharmaceuticals, Inc. other comprehensive income (loss), net of tax for fiscal 2024 was $26.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$42.00K 10-Q · filed 2026-08-13 | -$138.00K derived: sum of 2 quarters · filed 2026-08-13 | ||
| 2026-03-31 | -$96.00K 10-Q · filed 2026-08-13 | |||
| 2025-12-31 | -$2.00K 10-K · filed 2026-03-19 | |||
| 2025-09-30 | $57.00K 10-Q · filed 2025-11-14 | $27.00K derived: sum of 2 quarters · filed 2026-08-13 | -$17.00K derived: sum of 3 quarters · filed 2026-08-13 | |
| 2025-06-30 | -$30.00K 10-Q · filed 2026-08-13 | -$74.00K derived: sum of 2 quarters · filed 2026-08-13 | ||
| 2025-03-31 | -$44.00K 10-Q · filed 2026-08-13 | |||
| 2024-12-31 | $26.00K 10-K · filed 2026-03-19 | |||
| 2024-09-30 | $102.00K 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |